Thyroid Neoplasms: Clinical Trials

935 trials for Thyroid Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

390 completed, 179 unknown, 165 recruiting, 65 active not recruiting. 277 Not applicable, 209 Phase 2, 102 Phase 1, 40 Phase 3, 26 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable277Completed 111, Unknown 74, Recruiting 50, Not yet recruiting 15, Terminated 13, Active not recruiting 6, Withdrawn 5, Enrolling by invitation 2, Suspended 1
Phase 2209Completed 93, Active not recruiting 29, Recruiting 27, Terminated 26, Unknown 22, Not yet recruiting 7, Withdrawn 4, Suspended 1
Phase 1102Completed 48, Terminated 17, Active not recruiting 14, Recruiting 12, Unknown 4, Withdrawn 4, Not yet recruiting 3
Phase 340Completed 17, Recruiting 11, Unknown 5, Active not recruiting 4, Terminated 2, Withdrawn 1
Phase 426Completed 11, Unknown 5, Not yet recruiting 4, Recruiting 3, Terminated 2, Active not recruiting 1
Early Phase 17Completed 2, Recruiting 2, Unknown 2, Active not recruiting 1

Follow Thyroid Neoplasms: new trials by email Literature Review of Thyroid Neoplasms trials Research Report on Thyroid Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mapping Patient Decision-making in Thyroid Cancer
Decision navigation tool - Thyroid Cancer
Not applicableNot yet recruitingUniversity of California, Los Angeles502028-04-012026-07-24
Pre-Clinic Visit Online Education for Thyroid Cancer
THRIVE, ACS "After a Thyroid Cancer Diagnosis" Flyer - Thyroid Cancer
Not applicableNot yet recruitingCedars-Sinai Medical Center602027-08-012026-09-01
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
Diagnostic DNA Methylation Signature - Thyroid Gland Nodule
RecruitingCity of Hope Medical Center222027-01-012026-06-02
Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer
Dabrafenib, Trametinib, Pembrolizumab - Anaplastic Thyroid Carcinoma, Thyroid Cancer
Phase 2Not yet recruitingWashington University School of Medicine122026-12-312026-10-21
Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
Internet-Based Intervention, Interview, Questionnaire Administration - Differentiated Thyroid Gland Carcinoma, Malignant Testicular Neoplasm
Not applicableNot yet recruitingUniversity of Michigan Rogel Cancer Center1422026-12-012026-10-15
Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
Sacituzumab Tirumotecan - Recurrent Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma Metastatic
Phase 2Not yet recruitingNational Cancer Centre, Singapore682026-11-012026-07-15
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
68Ga-DOTA-TATE PET Scan, Amino acid infusions, 177Lu-DOTA-EB-TATE - Thyroid Cancer
Phase 1 / Phase 2Not yet recruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)182026-10-272026-10-22
Bethesda Classification and Risk Stratification in Differentiated Thyroid Carcinoma
Differentiated Thyroid Carcinoma, Papillary Thyroid Carcinoma
Not yet recruitingAssiut University1002026-10-262026-10-05
A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in India
Selpercatinib - Thyroid Neoplasms, Carcinoma, Non-Small-Cell Lung
Phase 4Not yet recruitingEli Lilly and Company302026-10-012026-10-08
Educational Videos for Thyroid Surgery Patient
Thyroid Surgery Educational Video - Thyroid Cancer, Thyroid Nodule
Not applicableNot yet recruitingWest China Hospital4002026-10-012026-09-16
MRG003 Added to Ongoing Treatment After Progression in EGFR-Positive Advanced Thyroid Cancer
Becotatug Vedotin (MRG003), Lenvatinib, Anti-PD-1 Inhibitor (Continuation of Prior Treatment) - Thyroid Cancer, Tumor
Phase 2RecruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University392026-09-202026-10-14
Pattern and Surgical Outcome of Papillary Thyroid Cancer at Sohag University Hospitals
Papillary Thyroid Carcinoma, Thyroid Cancer
Not yet recruitingSohag University302026-09-162026-09-16
Effectiveness of WeChat-Supported Neck Rehabilitation Exercises on Early Recovery After Thyroidectomy
WeChat-supported Neck Rehabilitation Exercise, Standardized Postoperative Care and Video Education - Thyroid Diseases, Thyroid Cancer
Not applicableRecruitingShanghai 6th People's Hospital2002026-09-092026-09-10
Thyroid Health Outcomes Registry for Surgery
Thyroid Diseases, Thyroid Neoplasms
Not yet recruitingPirogov Russian National Research Medical University30002026-09-012026-09-10
A Novel Ultrasound Probe for Thyroid Imaging and Machine Learning
Thyroid ultrasound - Thyroid Nodules, Thyroid Abnormalities
Not applicableRecruitingSound Blade Medical Inc.302026-09-012026-09-01
Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
Euthyrox (levothyroxine), Cytomel (liothyronine) - Differentiated Thyroid Cancer, Thyroid Cancer
Not yet recruitingUniversity Medical Center Groningen402026-09-012026-02-10
Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer
Selective coverage radiotherapy, comprehensive coverage radiotherapy - Thyroid Cancer
Phase 2RecruitingFudan University722026-08-122026-08-20
Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer
Compared the diagnostic performance of 68Ga-MY6349 PET/CT with 68Ga-FAPI PET/CT - Tumor, Solid Tumor
Not applicableRecruitingThe First Affiliated Hospital of Xiamen University1202026-08-012026-08-07
FAPI PET Imaging - An Exploratory Study
[18F]FAPI-74 PET/CT - Thyroid Pathology, Head and Neck Cancer (H&N)
Phase 1 / Phase 2Not yet recruitingMartin Huellner7702026-08-012026-07-15
Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients
Genomics, Thyroid Cancer
Not yet recruitingNational Taiwan University Hospital1002026-08-012026-04-20

Showing 20 of 935. Sign in to see all of them.

Narrower conditions

Thyroid Cancer, Papillary (183)  ·  Thyroid Nodule (183)  ·  Breast Neoplasms (71)  ·  Head and Neck Neoplasms (64)  ·  Thyroid Diseases (64)  ·  Adenocarcinoma, Follicular (62)  ·  Neoplasms (59)  ·  Melanoma (58)  ·  Carcinoma, Non-Small-Cell Lung (56)  ·  Carcinoma, Medullary (51)  ·  Prostatic Neoplasms (49)  ·  Colorectal Neoplasms (48)  ·  Ovarian Neoplasms (48)  ·  Pancreatic Neoplasms (48)

Broader conditions

Endocrine System Diseases (930)  ·  Neoplasms by Site (927)  ·  Endocrine Gland Neoplasms (925)  ·  Neoplasms (876)  ·  Head and Neck Neoplasms (871)  ·  Thyroid Diseases (871)  ·  Neoplasms by Histologic Type (330)  ·  Neoplasms, Glandular and Epithelial (299)  ·  Carcinoma (279)  ·  Adenocarcinoma (249)  ·  Adenocarcinoma, Papillary (182)  ·  Neoplasms, Nerve Tissue (131)  ·  Neoplasms, Germ Cell and Embryonal (130)  ·  Neuroectodermal Tumors (130)

Interventions

Iodine-131 (24)  ·  Magnetic Resonance Spectroscopy (21)  ·  lenvatinib (20)  ·  Thyroidectomy (16)  ·  Thyrotropin Alfa (15)  ·  trametinib (15)  ·  Sorafenib (13)  ·  dabrafenib (13)  ·  pembrolizumab (13)  ·  Radiofrequency Ablation (11)  ·  Surgical Procedures, Operative (11)  ·  Transurethral Resection of Prostate (10)  ·  selpercatinib (10)  ·  Paclitaxel (9)  ·  Thyroxine (9)

Sponsors

National Cancer Institute (NCI) (42)  ·  Memorial Sloan Kettering Cancer Center (25)  ·  Fujian Medical University (17)  ·  M.D. Anderson Cancer Center (17)  ·  Assiut University (16)  ·  Fudan University (15)  ·  Yonsei University (13)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (11)  ·  Chinese PLA General Hospital (10)  ·  Mayo Clinic (9)  ·  National Taiwan University Hospital (9)  ·  Seoul National University Hospital (9)  ·  Eli Lilly and Company (8)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (8)  ·  University Health Network, Toronto (8)

Countries

United States (319)  ·  China (182)  ·  France (73)  ·  Italy (72)  ·  South Korea (70)  ·  Canada (47)  ·  Spain (38)  ·  United Kingdom (38)  ·  Germany (32)  ·  Netherlands (32)  ·  Denmark (29)  ·  Australia (28)  ·  Turkey (Türkiye) (27)  ·  Taiwan (24)  ·  Israel (22)

Top investigators

Yukun Luo (5)  ·  Joanna Klubo-Gwiezdzinska, M.D. (4)  ·  Kiyohiko Mabuchi, M.D. (4)  ·  Naris Nilubol, M.D. (4)  ·  Alan Ho, MD, PhD (3)  ·  Douglas Van Nostrand, MD (3)  ·  Electron Kebebew, MD (3)  ·  Eric Sherman, MD (3)  ·  Manisha Shah (3)

Results publications

PMID 37934000, PMID 40341199, PMID 40668552, PMID 27240885, PMID 31838007, PMID 32612576, PMID 33570641, PMID 33720068, PMID 36657661, PMID 37171634, PMID 37816266, PMID 40086048, PMID 11442004, PMID 11875733, PMID 12225640, PMID 12541136, PMID 12660642, PMID 12800205, PMID 14557134, PMID 14652672, PMID 14668957, PMID 15068625, PMID 15319714, PMID 15551359, PMID 15588952, PMID 15855141, PMID 16125070, PMID 16339287, PMID 16384850, PMID 16400382, PMID 16511940, PMID 16522694, PMID 16964393, PMID 17131394, PMID 17143968, PMID 17278943, PMID 17299648, PMID 17885154, PMID 17985341, PMID 17985985, PMID 18281176, PMID 18323549, PMID 18366712, PMID 18382668, PMID 18438123, PMID 18469262, PMID 18596272, PMID 18854394, PMID 19017880, PMID 19022998

NIH funding

2016 (5), P30CA015083 (5), 2023 (4), N01CM62207 (4), 2015 (3), 2019 (3), N01CM00099 (3), N01CM62201 (3), N01CM62206 (3), P30CA008748 (3), P30CA016672 (3), 2005 (2), 2014 (2), 2018 (2), 2025 (2)